Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Alopecia and HR[original query] |
---|
The hairless gene in androgenetic alopecia: results of a systematic mutation screening and a family-based association approach. The British journal of dermatology 2002 Apr 146 (4): 601-8. Hillmer A M, Kruse R, Macciardi F, Heyn U, Betz R C, Ruzicka T, Propping P, Nöthen M M, Cichon |
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. The Lancet. Oncology 2010 Feb 11 (2): 121-8. Mitsudomi Tetsuya, Morita Satoshi, Yatabe Yasushi, Negoro Shunichi, Okamoto Isamu, Tsurutani Junji, Seto Takashi, Satouchi Miyako, Tada Hirohito, Hirashima Tomonori, Asami Kazuhiro, Katakami Nobuyuki, Takada Minoru, Yoshioka Hiroshige, Shibata Kazuhiko, Kudoh Shinzoh, Shimizu Eiji, Saito Hiroshi, Toyooka Shinichi, Nakagawa Kazuhiko, Fukuoka Masahiro, |
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. The Lancet. Oncology 2015 Jan 16 (1): 87-97. Oza Amit M, Cibula David, Benzaquen Ana Oaknin, Poole Christopher, Mathijssen Ron H J, Sonke Gabe S, Colombo Nicoletta, Špa?ek Ji?í, Vuylsteke Peter, Hirte Holger, Mahner Sven, Plante Marie, Schmalfeldt Barbara, Mackay Helen, Rowbottom Jacqui, Lowe Elizabeth S, Dougherty Brian, Barrett J Carl, Friedlander Micha |
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2018 Mar 117 44-49. Gerber David E, Socinski Mark A, Neal Joel W, Wakelee Heather A, Shirai Keisuke, Sequist Lecia V, Rosovsky Rachel P, Lilenbaum Rogerio C, Bastos Bruno R, Huang Chao, Johnson Melissa L, Hesketh Paul J, Subramaniam Deepa S, Dietrich Martin F, Chai Feng, Wang Yunxia, Kazakin Julia, Schwartz Brian, Schiller Joan H, Brahmer Julie R, Kelly Ronan |
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer. Breast cancer research and treatment 2020 8 184 (1): 53-62. Diamond Jennifer R, Becerra Carlos, Richards Donald, Mita Alain, Osborne Cynthia, O'Shaughnessy Joyce, Zhang Chun, Henner Randall, Kapoun Ann M, Xu Lu, Stagg Bob, Uttamsingh Shailaja, Brachmann Rainer K, Farooki Azeez, Mita Moni |
Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy. JNCI cancer spectrum 2020 4 4 (1): pkz085. Rugo Hope S, Ettl Johannes, Hurvitz Sara A, Gonçalves Anthony, Lee Kyung-Hun, Fehrenbacher Louis, Mina Lida A, Diab Sami, Woodward Natasha E, Yerushalmi Rinat, Goodwin Annabel, Blum Joanne L, Martin Miguel, Quek Ruben G W, Tudor Iulia Cristina, Bhattacharyya Helen, Gauthier Eric, Litton Jennifer K, Eiermann Wolfga |
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 11 27 (7): 1842-1849. Narayan Preeti, Prowell Tatiana M, Gao Jennifer J, Fernandes Laura L, Li Emily, Jiang Xiling, Qiu Junshan, Fan Jianghong, Song Pengfei, Yu Jingyu, Zhang Xinyuan, King-Kallimanis Bellinda L, Chen Wei, Ricks Tiffany K, Gong Yutao, Wang Xing, Windsor Katherine, Rhieu Steve Y, Geiser Gerlie, Banerjee Anamitro, Chen Xiaohong, Reyes Turcu Francisca, Chatterjee Deb K, Pathak Anand, Seidman Jeffrey, Ghosh Soma, Philip Reena, Goldberg Kirsten B, Kluetz Paul G, Tang Shenghui, Amiri-Kordestani Laleh, Theoret Marc R, Pazdur Richard, Beaver Julia |
A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer. Breast cancer research and treatment 2020 10 185 (1): 135-144. Filho Otto Metzger, Giobbie-Hurder Anita, Lin Nancy U, Faggen Meredith, Come Steven, Openshaw Thomas, Constantine Michael, Walsh Jeanna, Freedman Rachel A, Schneider Bryan, Burstein Harold J, Mayer Erica |
Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China. Advances in therapy 2023 6 . Xinhua Zhang, Peng Zhang, Haibo Qiu, Yong Fang, Heli Liu, Yongjian Zhou, Hao Xu, JiRen Yu, Jun Zhang, Ming Wang, Lin Shen, Jian |
HR Gene Variants Identified in Mexican Patients with Alopecia Areata. Current issues in molecular biology 2023 5 45 (4): 2965-2971. Andrés Ortiz-Ramírez, María Cristina Hernández-Jiménez, Iliana Berenice Guardiola-Avila, Erick de Jesús De Luna-Santillana, Amanda Alejandra Oliva-Hernández, María Lourdes Altamirano-García, Karina Janett Juárez-Rend |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: